New Delhi: Pharmaceutical giant AstraZeneca has announced the global withdrawal of its Covid-19 vaccine. The company cited a surplus of newer vaccine options as the primary reason behind this decision.
AstraZeneca has voluntarily withdrawn the “marketing authorization” for the vaccine within the European Union, with similar applications expected to be made in other countries where the vaccine was previously approved.
This decision comes amidst ongoing legal battles faced by AstraZeneca, including allegations linking its vaccine, developed in collaboration with the University of Oxford, to fatalities and severe injuries, notably Thrombosis with Thrombocytopenia Syndrome (TTS).
However, the company has clarified that the withdrawal is not directly linked to ongoing court cases or its admission of TTS side effects. Instead, AstraZeneca attributed the decision to commercial reasons and a decline in demand for the vaccine.
“As multiple variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines,” stated AstraZeneca in a released statement.
Bhubaneswar: The International Odissi Dance Festival, jointly organised by the Guru Kelucharan Mohapatra Odissi Research…
Bhubaneswar: A major step towards strengthening wildlife conservation while empowering local women, the Hirakud Wildlife…
Bhubaneswar: As many as 127 NCC cadets from Odisha have been selected to participate in…
Bhubaneswar: The International Odissi Dance Festival was inaugurated with grandeur at Rabindra Mandap on Thursday,…
Bhubaneswar: The State Youth Festival–2025, celebrating the creativity, talent and youthful energy of Odisha, concluded…
Bhubaneswar: Odisha has achieved a major milestone in its digital agriculture transformation, with the Government…
